🟢 Connect Biopharma is trading 6.45% up in pre-market with no clear company-specific catalyst identified

Connect Biopharma is trading at $2.05, up 6.45% in pre-market after falling 30.07% during the September 3, 2026 regular session; no clear company-specific catalyst was identified.

• The September 3 announcement only scheduled management’s September 15 H.C. Wainwright fireside chat.
• September topline trial results remain an anticipated catalyst, but current evidence does not directly link them to this move.